Skip to main content

Advertisement

SpringerLink
Log in

The association between antihypertensive drug therapies and plasma lipid levels in the general population

  • Original Article
  • Published:
Journal of Human Hypertension Submit manuscript

Abstract

Objective: To assess the association between different antihypertensive drug regimens and plasma lipid levels in the general population.

Methods: The Monitoring Project on Cardiovascular Risk Factors was conducted from 1987 to 1991 as a cross-sectional study in The Netherlands. Antihypertensive drug-users and untreated hypertensives were selected. After exclusion of users of cholesterol-lowering drugs 2997 subjects remained for the analysis. The plasma lipid concentrations of the users and non-users of antihypertensives were compared by multiple linear regression.

Results: In the univariate analysis patients using beta-blockers had lower high-density lipoprotein (HDL) concentrations (1.13 mmol/l, P < 0.05) and higher cholesterol ratios (5.74, P < 0.05) than untreated hypertensives (Total cholesterol = 6.07 mmol/l, HDL = 1.20 mmol/l and ratio = 5.44). Patients using diuretics had higher total cholesterol levels (6.34 mmol/l) and higher HDL levels (1.26 mmol/l) compared to untreated hypertensives. After adjustment for possible confounders these differences were smaller and no longer statistically significant. After adjustment we found a significant lower HDL cholesterol (mean difference of −0.10 mmol/l, P < 0.05) for users of a combination of a beta-blocker and a diuretic.

Conclusions: Although randomised, controlled trials have demonstrated that antihypertensive drugs may influence plasma lipid levels we observed no substantial association for single antihypertensive drug therapy in the general population. The combination of a diuretic and a beta-blocker was associated with a worse lipid profile.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kasiske BL, Ma JZ, Kalil RSN, Louis TA Effects of antihypertensive therapy on serum lipids Ann Intern Med 1995 122 133–141

    Article  CAS  Google Scholar 

  2. Lakshman MR et alDiuretics and β-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension Arch Intern Med 1999 159 551–558

    Article  CAS  Google Scholar 

  3. Moser M Why are physicians not prescribing diuretics more frequently in the management of hypertension? JAMA 1998 279 1813–1816

    Article  CAS  Google Scholar 

  4. Howes LG, Lykos D, Rennie GC Effects of antihypertensive drugs on coronary artery disease risk; a meta analysis Clin Exper Pharmacol Physiol 1996 23 555–558

    Article  CAS  Google Scholar 

  5. Dimmitt SB, Williams PD, Croft KD, Beilin LJ Effects of beta-blockers on the concentration and oxidizability of plasma lipids Clin Sci Colch 1998 94 573–578

    Article  CAS  Google Scholar 

  6. Fogari R et alBeta-blocker effects on plasma lipids during prolonged treatment of hypertensivepatients with hypercholesterolemia J Cardiovasc Pharmacol 1999 33 534–539

    Article  CAS  Google Scholar 

  7. Weidman P, Courten de M, Ferrari P, Bohlen L Serum lipoproteins during treatment with antihypertensive drugs J Cardiovasc Pharmacol 1993 22 (Suppl 6) S98–S105

    Article  Google Scholar 

  8. Grimm RH et alLong-term effects on plasma lipids of diet and drugs to treat hypertension JAMA 1996 275 1549–1556

    Article  CAS  Google Scholar 

  9. Strickland D, Sprafka JM, Luepker RV, Grimm RH Jr Association of antihypertensive agents and blood lipids in a population-based survey Epidemiology 1994 5 96–101

    Article  CAS  Google Scholar 

  10. Hense HW, Doring A, Stieber J, Keil U The association of antihypertensive treatment patterns and adverse lipid effects in population-based studies J Clin Epidemiol 1992 45 1423–1430

    Article  CAS  Google Scholar 

  11. Helmert U, Shea S Antihypertensive treatment and serum cholesterol: results of population-based surveys in the German Cardiovascular Prevention Study Rev Environ Health 1997 12 253–260

    CAS  PubMed  Google Scholar 

  12. Goode GK, Miller JP, Heagerty AM Hyperlipidaemia, hypertension, and coronary heart disease Lancet 1995 345 362–364

    Article  CAS  Google Scholar 

  13. Klungel OH et alUndertreatment of hypertension in a population-based study in The Netherlands J Hypertens 1998 16 1371–1378

    Article  CAS  Google Scholar 

  14. Verschuren WMM et alCardiovascular disease risk factors in The Netherlands Netherlands J Cardiol 1993 6 205–210

    Google Scholar 

  15. Klungel OH et alAgreement between self-reported antihypertensive drug use and pharmacy records in a populationbased study in the Netherlands Pharm World Sci 1999 21 217–220

    Article  CAS  Google Scholar 

  16. Weir MR, Flack JM, Applegate WB Tolerability, safety and quality of life and hypertensive therapy: the case for low-dose diuretics Am J Med 1996 101 (Suppl 3A) 83S–93S

    Article  Google Scholar 

  17. Psaty BM et alHealth outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis JAMA 1997 277 739–745

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands

    AH Maitland-van der Zee, OH Klungel, JME Kloosterman, HGM Leufkens & A de Boer

  2. Department of Chronic Diseases and Environmental Epidemiology, National Institute of Public Health and the Environment, Bilthoven, The Netherlands

    JC Seidell

Authors
  1. AH Maitland-van der Zee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. OH Klungel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. JME Kloosterman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. JC Seidell
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. HGM Leufkens
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A de Boer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to AH Maitland-van der Zee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maitland-van der Zee, A., Klungel, O., Kloosterman, J. et al. The association between antihypertensive drug therapies and plasma lipid levels in the general population. J Hum Hypertens 15, 701–705 (2001). https://doi.org/10.1038/sj.jhh.1001197

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001197

  • Springer Nature Limited

Keywords

This article is cited by

Search

Navigation